Aster Insights
Michelle Churchman, PhD has extensive work experience in the scientific research field. Michelle started their career at St. Jude Children's Research Hospital in 2007 as a Postdoctoral Research Associate and held this position until 2011. Michelle then became a Research Laboratory Specialist before transitioning to the role of Staff Scientist from 2012 to 2016. In 2016, they joined Aster Insights as a Scientific Manager. At Aster Insights, they worked on various projects and eventually became a Senior Scientific Research Project Lead until 2021. Currently, Michelle is the Scientific Director at Aster Insights.
Michelle Churchman earned their Doctor of Philosophy (PhD) degree in Biochemistry from Louisiana State University, completing their studies from 2001 to 2007.
This person is not in any teams
Aster Insights
We believe that personalized medicine starts with a complete view of an individual across their lifetime. Our company was founded in 2006 on the unique principle that informed consent from patients entrusting us with a lifetime connection to their health information, paired with deep partnerships across academia and the life sciences industry, would unlock critical advances in curing cancer. Aster Insights leads the Oncology Research Information Exchange Network (ORIEN®), a consortium of the nation’s leading academic cancer centers that conduct Total Cancer Care®, the world’s largest and longest running observational research study in oncology. TCC® serves as the foundation for novel insights that power oncology breakthroughs. As a long-time innovator in oncology, Aster Insights has world-class expertise in accelerating the life cycle of oncology medical product development. Our solutions are based on scientific and clinical intelligence and strengthened by our unique partnership with patients, academia, and industry. We empower our partners to uncover new targets and biomarkers, enhance cancer detection, deepen our understanding of new treatments, discover new indications, and accelerate clinical trials. Together, we are changing the way cancer is studied, treated, and prevented.